Recorded Webinar Evaluation: Leishmaniasis and Malaria

Recorded on January 20, 2022
Center for Excellence in Newcomer Health

Which section(s) of the webinar did you view?

Hour 1 only: Screening and diagnosis
Hour 2 only: Clinical management
Both Hour 1 and 2

CME:

I need a CME certificate
I do not need a CME certificate

If you need a CME certificate, please open the CME Requests form now and fill it out after completing this evaluation.

You will be redirected to a proof of attendance document once you submit this survey. If applicable, please download, save, or print as evidence of attending up to two (2) hours of continuing education from the Minnesota Department of Health.

State:

Select one:

Do you perform initial health assessments for refugees?

Do you provide ongoing primary care to refugees?

Indicate your level of agreement with each of the following Hour 1 webinar objectives.

Topics	Strongly Disagree	Disagree	Neutral	Agree	Strongly Agree
I can review the epidemiology of malaria in Afghanistan.	I can review the epidemiology of malaria in Afghanistan., Strongly Disagree	I can review the epidemiology of malaria in Afghanistan., Disagree	I can review the epidemiology of malaria in Afghanistan., Neutral	I can review the epidemiology of malaria in Afghanistan., Agree	I can review the epidemiology of malaria in Afghanistan., Strongly Agree
I can describe best practices for timely diagnosis and treatment of malaria in the United States.	I can describe best practices for timely diagnosis and treatment of malaria in the United States., Strongly Disagree	I can describe best practices for timely diagnosis and treatment of malaria in the United States., Disagree	I can describe best practices for timely diagnosis and treatment of malaria in the United States., Neutral	I can describe best practices for timely diagnosis and treatment of malaria in the United States., Agree	I can describe best practices for timely diagnosis and treatment of malaria in the United States., Strongly Agree
I can describe the causal agents, epidemiology, and transmission of leishmaniasis in Afghanistan.	I can describe the causal agents, epidemiology, and transmission of leishmaniasis in Afghanistan., Strongly Disagree	I can describe the causal agents, epidemiology, and transmission of leishmaniasis in Afghanistan., Disagree	I can describe the causal agents, epidemiology, and transmission of leishmaniasis in Afghanistan., Neutral	I can describe the causal agents, epidemiology, and transmission of leishmaniasis in Afghanistan., Agree	I can describe the causal agents, epidemiology, and transmission of leishmaniasis in Afghanistan., Strongly Agree
I can describe the main forms of leishmaniasis in Afghanistan, their associated signs and symptoms, and differential diagnosis.	I can describe the main forms of leishmaniasis in Afghanistan, their associated signs and symptoms, and differential diagnosis., Strongly Disagree	I can describe the main forms of leishmaniasis in Afghanistan, their associated signs and symptoms, and differential diagnosis., Disagree	I can describe the main forms of leishmaniasis in Afghanistan, their associated signs and symptoms, and differential diagnosis., Neutral	I can describe the main forms of leishmaniasis in Afghanistan, their associated signs and symptoms, and differential diagnosis., Agree	I can describe the main forms of leishmaniasis in Afghanistan, their associated signs and symptoms, and differential diagnosis., Strongly Agree
I can recommend appropriate next steps for patients with findings concerning for leishmaniasis thought to be acquired in Afghanistan.	I can recommend appropriate next steps for patients with findings concerning for leishmaniasis thought to be acquired in Afghanistan., Strongly Disagree	I can recommend appropriate next steps for patients with findings concerning for leishmaniasis thought to be acquired in Afghanistan., Disagree	I can recommend appropriate next steps for patients with findings concerning for leishmaniasis thought to be acquired in Afghanistan., Neutral	I can recommend appropriate next steps for patients with findings concerning for leishmaniasis thought to be acquired in Afghanistan., Agree	I can recommend appropriate next steps for patients with findings concerning for leishmaniasis thought to be acquired in Afghanistan., Strongly Agree

Indicate your level of agreement with each of the following Hour 2 webinar objectives.

Topics	Strongly Disagree	Disagree	Neutral	Agree	Strongly Agree
I can describe approaches for P. vivax malaria anti-relapse therapy.	I can describe approaches for P. vivax malaria anti-relapse therapy., Strongly Disagree	I can describe approaches for P. vivax malaria anti-relapse therapy., Disagree	I can describe approaches for P. vivax malaria anti-relapse therapy., Neutral	I can describe approaches for P. vivax malaria anti-relapse therapy., Agree	I can describe approaches for P. vivax malaria anti-relapse therapy., Strongly Agree
I can review considerations for treatment of malaria in pregnancy and other special situations.	I can review considerations for treatment of malaria in pregnancy and other special situations., Strongly Disagree	I can review considerations for treatment of malaria in pregnancy and other special situations., Disagree	I can review considerations for treatment of malaria in pregnancy and other special situations., Neutral	I can review considerations for treatment of malaria in pregnancy and other special situations., Agree	I can review considerations for treatment of malaria in pregnancy and other special situations., Strongly Agree
I can describe the appropriate physical examination, specimen collection, and diagnostic testing for simple and complex cutaneous leishmaniasis acquired in Afghanistan.	I can describe the appropriate physical examination, specimen collection, and diagnostic testing for simple and complex cutaneous leishmaniasis acquired in Afghanistan., Strongly Disagree	I can describe the appropriate physical examination, specimen collection, and diagnostic testing for simple and complex cutaneous leishmaniasis acquired in Afghanistan., Disagree	I can describe the appropriate physical examination, specimen collection, and diagnostic testing for simple and complex cutaneous leishmaniasis acquired in Afghanistan., Neutral	I can describe the appropriate physical examination, specimen collection, and diagnostic testing for simple and complex cutaneous leishmaniasis acquired in Afghanistan., Agree	I can describe the appropriate physical examination, specimen collection, and diagnostic testing for simple and complex cutaneous leishmaniasis acquired in Afghanistan., Strongly Agree
I can describe the treatment options and expected response to treatment for simple and complex cutaneous leishmaniasis acquired in Afghanistan.	I can describe the treatment options and expected response to treatment for simple and complex cutaneous leishmaniasis acquired in Afghanistan., Strongly Disagree	I can describe the treatment options and expected response to treatment for simple and complex cutaneous leishmaniasis acquired in Afghanistan., Disagree	I can describe the treatment options and expected response to treatment for simple and complex cutaneous leishmaniasis acquired in Afghanistan., Neutral	I can describe the treatment options and expected response to treatment for simple and complex cutaneous leishmaniasis acquired in Afghanistan., Agree	I can describe the treatment options and expected response to treatment for simple and complex cutaneous leishmaniasis acquired in Afghanistan., Strongly Agree

Indicate your level of agreement with each of the following statements.

Topics	Strongly Disagree	Disagree	Neutral	Agree	Strongly Agree
Holly Biggs' presentation was effective.	Holly Biggs' presentation was effective., Strongly Disagree	Holly Biggs' presentation was effective., Disagree	Holly Biggs' presentation was effective., Neutral	Holly Biggs' presentation was effective., Agree	Holly Biggs' presentation was effective., Strongly Agree
Andrew Abbott's presentation was effective.	Andrew Abbott's presentation was effective., Strongly Disagree	Andrew Abbott's presentation was effective., Disagree	Andrew Abbott's presentation was effective., Neutral	Andrew Abbott's presentation was effective., Agree	Andrew Abbott's presentation was effective., Strongly Agree

Indicate your level of agreement with each of the following statements.

Topics	Strongly Disagree	Disagree	Neutral	Agree	Strongly Agree
Alexia Knapp's presentation was effective.	Alexia Knapp's presentation was effective., Strongly Disagree	Alexia Knapp's presentation was effective., Disagree	Alexia Knapp's presentation was effective., Neutral	Alexia Knapp's presentation was effective., Agree	Alexia Knapp's presentation was effective., Strongly Agree
Naomi Aronson's presentation was effective.	Naomi Aronson's presentation was effective., Strongly Disagree	Naomi Aronson's presentation was effective., Disagree	Naomi Aronson's presentation was effective., Neutral	Naomi Aronson's presentation was effective., Agree	Naomi Aronson's presentation was effective., Strongly Agree
Christina Coyle's presentation was effective.	Christina Coyle's presentation was effective., Strongly Disagree	Christina Coyle's presentation was effective., Disagree	Christina Coyle's presentation was effective., Neutral	Christina Coyle's presentation was effective., Agree	Christina Coyle's presentation was effective., Strongly Agree
William Stauffer's presentation was effective.	William Stauffer's presentation was effective., Strongly Disagree	William Stauffer's presentation was effective., Disagree	William Stauffer's presentation was effective., Neutral	William Stauffer's presentation was effective., Agree	William Stauffer's presentation was effective., Strongly Agree

Indicate your level of agreement with each of the following statements.

Topics	Strongly Disagree	Disagree	Neutral	Agree	Strongly Agree
The webinar session format worked well.	The webinar session format worked well., Strongly Disagree	The webinar session format worked well., Disagree	The webinar session format worked well., Neutral	The webinar session format worked well., Agree	The webinar session format worked well., Strongly Agree
The webinar was relevant to my work.	The webinar was relevant to my work., Strongly Disagree	The webinar was relevant to my work., Disagree	The webinar was relevant to my work., Neutral	The webinar was relevant to my work., Agree	The webinar was relevant to my work., Strongly Agree
Overall, the webinar met my expectations.	Overall, the webinar met my expectations., Strongly Disagree	Overall, the webinar met my expectations., Disagree	Overall, the webinar met my expectations., Neutral	Overall, the webinar met my expectations., Agree	Overall, the webinar met my expectations., Strongly Agree

As a result of participating in this training:

Topics	Yes	No	N/A
Was the length of this webinar appropriate?	Was the length of this webinar appropriate?, Yes	Was the length of this webinar appropriate?, No	Was the length of this webinar appropriate?, N/A
Would you recommend this webinar to a colleague?	Would you recommend this webinar to a colleague?, Yes	Would you recommend this webinar to a colleague?, No	Would you recommend this webinar to a colleague?, N/A
As a result of participating in this webinar, will you make any significant changes in your work?	As a result of participating in this webinar, will you make any significant changes in your work?, Yes	As a result of participating in this webinar, will you make any significant changes in your work?, No	As a result of participating in this webinar, will you make any significant changes in your work?, N/A
Will your participation in this webinar improve your patient outcomes?	Will your participation in this webinar improve your patient outcomes?, Yes	Will your participation in this webinar improve your patient outcomes?, No	Will your participation in this webinar improve your patient outcomes?, N/A

What significant changes will you make in your work? Please provide example(s) that you intend to apply in practice with a health care team.

Suggestions for future Center of Excellence in Newcomer Health webinars or additional tools, education, and resources that would be helpful to you:

Additional comments (content, presenters, format, etc.)?